Top Markets
Coin of the day
NeuroSense Therapeutics Ltd. NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd.

NRSN
Peringkat dalam Saham #31257
NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical... NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical development phase, committed to discovering and developing effective therapies for individuals suffering from severe neurodegenerative conditions. The company's leading drug candidate, PrimeC, is an innovative oral formulation that has successfully concluded Phase IIa clinical investigations for the management of amyotrophic lateral sclerosis (ALS). Additionally, its early-stage research pipeline features StabiliC, a potential treatment for Parkinson's disease, and CogniC, which is under development for Alzheimer's disease. Established in 2017, NeuroSense Therapeutics Ltd. is headquartered in Herzliya, Israel.
Harga Saham
$0.39
Kapitalisasi Pasar
$13.79M
Perubahan (1 hari)
-13.53%
Perubahan (1 tahun)
-68.80%
Negara
IL
Perdagangan NeuroSense Therapeutics Ltd. (NRSN)

Kategori

Riwayat pemecahan saham untuk NeuroSense Therapeutics Ltd. (NRSN)
Saham NeuroSense Therapeutics Ltd. (simbol: NRSN) telah mengalami total 0 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Aug 18, 2026.
Satu lembar saham NRSN yang dibeli sebelum Aug 18, 2026 sekarang setara dengan 0 lembar saham NRSN.
Daftar pemecahan saham
Tahun Pemecahan Kelipatan Kelipatan Kumulatif
Tidak cukup data untuk tanggal yang disediakan.
Pemecahan saham untuk perusahaan sejenis atau pesaing
Perusahaan Jumlah pemecahan saham Kelipatan Kumulatif Negara
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
BE